Open AccessCurrent management and prognosis of patients with recurrent myocardial infarction
Author(s) -
Leonardo De Luca,
Luca Paolucci,
Annunziata Nusca,
Rita Lucia Putini,
Fabio Mangiacapra,
Enrico Natale,
Gian Paolo Ussia,
Furio Colivicchi,
Francesco Grigioni,
Francesco Musumeci,
Domenico Gabrielli
Publication year - 2021
Publication title -
reviews in cardiovascular medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.555
H-Index - 39
eISSN - 2153-8174
pISSN - 1530-6550
DOI - 10.31083/j.rcm2203080
Subject(s) - medicine , myocardial infarction , epidemiology , acute coronary syndrome , revascularization , cardiology , secondary prevention , intensive care medicine , myocardial revascularization
Recurrent myocardial infarction (re-MI) is a common event following acute coronary syndrome (ACS), especially during the first year. According to epidemiological studies, patients who experience re-MI are at higher risk of all-cause cardiovascular events and mortality. The cornerstones of re-MI prevention include complete functional coronary revascularization, effective dual antiplatelet therapy and secondary prevention strategies. Notwithstanding this, some controversy still exists on the definition and management of re-MI, and no dedicated studies have been designed or conducted so far in this setting. We here provide an overview of epidemiological and prognostic data on ACS patients experiencing re-MI, along with current available treatment and preventive options.